Conquering Triple-Negative Disease: Innovations in the Most...

added blog Health

2025-12-01 12:47:10 -

Conquering Triple-Negative Disease: Innovations in the Most Aggressive Segment of the HER2 Negative Market

Triple-Negative Breast Cancer (TNBC) represents the most challenging and aggressive subset within the HER2 negative breast cancer market Lacking the three common targets (estrogen receptor, progesterone receptor, and HER2 protein), treatment for TNBC has historically relied heavily on traditional chemotherapy However, recent scientific breakthroughs have revolutionized this...

0 Comments 0 Shares 431 Views 0 Reviews